Skin Care Today

44 / 48

44 SKIN CARE TODAY 2017,Vol 3, No 1
i FOCUS ON VENOUS ECZEMA
SCT
Figure 7. Patient’s leg after ten days of treatment for infected venous eczema.
pillows can be put under the
mattress to elevate the foot of
the bed.
CONCLUSION
Venous disease and venous eczema
can affect quality of life (González-
Consuegra and Verdú, 2011;
Maddox, 2012), and if not managed
appropriately can lead to further
deterioration in health and quality of
life. Healthcare professionals are in
a unique position to work with the
person to treat existing problems and
manage venous disease to reduce
the risk of further complications and
improve well-being.
REFERENCES
AbrahamA, Roga G (2014) Topical steroid-
damaged skin. Indian J Dermatol 59(5):
456–59
Ashby RL, Gabe R, Ali S, et al (2013)
Clinical and cost-effectiveness of
compression hosiery versus compression
bandages in treatment of venous leg
ulcers (Venous leg Ulcer Study IV,VenUS
IV): a randomised controlled trial. Lancet
383(9920): 871–9
Barron GS, Jacob SE, Kirsner RS (2007)
Dermatologic complications of chronic
venous disease: medical management
and beyond. AnnVasc Surg 21(5): 652–62
Beldon P (2006) Avoiding allergic contact
dermatitis in patients with venous leg
ulcers. Br J Community Nurs 11(3): S6–S10
Beldon P (2010) Performing a Doppler
assessment: the procedure. Wound
Essentials 5: 87–90
Bergan JJ, Schmid-Schönbein GW, Smith
PD, et al (2006) Chronic venous disease.
N Engl J Med 355: 488–98
British Association of Dermatologists
(2015) How to use potassium permanganate
soaks. BAD, London. Available online:
ashx?id=3637&itemtype=document
British Association of Dermatologists (2016)
Venous eczema. BAD, London. Available
online:
patient-information-leaflets/venous-ecz
ema/?showmore=1&returnlink=http%
3a%2f%2 %2ffor-the-
public%2fpatient-information-leaflets#.
VplGs0aRSUk
British Dermatological Nursing Group
(2012) Best practice in emollient therapy:
a statement for healthcare professionals .
BDNG. Available online: .
uk/documents/EmollientBPG.pdf
British National Formulary (2016) Topical
corticosteroid preparation potencies. Skin
Section 13: 4: Topical corticosteroids. BNF,
London. Available online: .
nhs.uk/formulary/bnf/current/13-
skin/134-topical-corticosteroids/topical-
corticosteroid-preparation-potencies
Carpentier PH, Maricq HR, Biro C,
Ponçot-Makinen CO, Franco A (2004)
Prevalence, risk factors, and clinical
patterns of chronic venous disorders of
lower limbs: a population-based study in
France. J Vasc Surg 40: 650–9
Cox NH (2002) Management of lower leg
cellulitis. Clin Med 2: 23–7
ChiYW, Raffetto JD (2015)Venous leg
ulceration pathophysiology and evidence
based treatment. Vasc Med 20(2): 168–81
David CV, Chira S, Eells SJ, et al (2011)
Diagnostic accuracy in patients admitted
to hospitals with cellulitis. Dermatol
Online J 1517(3): 1. Available online:
originals/1_10-00308/article.html
Department of Health (2011) Start Active,
Stay Active. A report on physical activity
from the four home countries’ Chief Medical
Officers. DH, London. Available online:
system/uploads/attachment_data/
file/216370/dh_128210.pdf
Eklof B, Rutherford RB, Bergan JJ, et al
(2004) Revision of the CEAP classification
for chronic venous disorders: consensus
statement. J Vasc Surg 40(1): 248–52
Finlay AY, Edwards PH, Harding KG (1989)
‘Fingertip unit’in dermatology. Lancet
2(8655): 155
Gawkrodger DJ (2006) Dermatology: An
Illustrated Colour Text. 3rd edn. Churchill
Livingstone, London
González-Consuegra RV,Verdú J (2011)
Quality of life in people with venous leg
ulcers: an integrative review. J Adv Nurs
67(5): 926–44
Graham ID, Harrison MB, Nelson EA,
Lorimer K, Fisher A (2003) Prevalence
of lower-limb ulceration: a systematic
review of prevalence studies. Adv Skin
Wound Care 16: 305e16. Available online:
causing-your-patients-lower-extremity-
redness_vol2-no4/
Grudzinska E, Czuba ZP (2014)
Immunological aspects of chronic
venous disease pathogenesis.Cent Eur J
Immunol 39(4): 525–31. Available online:
PMC4439967/
Ladva S (2012) Can topical steroids be